Prevagen® Orange Chewable Tablets Perspective: front
Hover to Zoom
Prevagen® Orange Chewable Tablets Perspective: back
Hover to Zoom
Prevagen® Orange Chewable Tablets Perspective: left
Hover to Zoom
Prevagen® Orange Chewable Tablets Perspective: right
Hover to Zoom
Prevagen® Orange Chewable Tablets Perspective: bottom
Hover to Zoom

Prevagen® Orange Chewable Tablets

30 ctUPC: 0089404700139
Purchase Options
$39.95

Product Details

It is common to experience forgetfulness as a normal part of aging. Prevagen® is a daily dietary supplement that has been clinically shown to help people with mild memory problems that are frequently associated with aging.* Prevagen® is the only supplement that is formulated with apoaequorin, an ingredient originally discovered in jellyfish, and has been shown to support healthy brain function.* Prevagen® is the only source of apoaequorin. This important supplement has been shown to improve certain aspects of cognitive function over a 90-day period in a computer-assessed, double-blinded, placebo-controlled clinical study** in people over 40 years old, taking just one capsule per day.* If you or someone you know is experiencing memory-related issues, prevagen can be an excellent way to improve memory and brain health.* While there are no known contraindications with any medications or other dietary supplements, you may want to talk with your doctor before beginning to take prevagen.

  • Prevagen® contains added vitamin D, an essential nutrient for overall health.
  • While originally discovered in jellyfish, Prevagen is now produced in a controlled scientific process.
  • Prevagen® is manufactured according to strict industry standard good manufacturing practices and certified by NSF international.
  • Prevagen® has been available for over a decade with millions of customers.
  • Prevagen® is not a drug and does not require a prescription.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

**a clinical study of subgroups of individuals who were cognitively normal or mildly impaired.